Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$295.33

-5.03 (-1.67%)

, SYMC

Symbol changed to NLOK

$22.11

0.06 (0.27%)

18:36
07/02/19
07/02
18:36
07/02/19
18:36

Broadcom in advanced talks to buy Symantec, Bloomberg reports

Broadcom (AVGO) is in advanced discussions to acquire Symantec (SYMC), Bloomberg reports, citing people familiar with the matter. Broadcom could reach a deal to buy the cybersecurity software maker within weeks, the report says.

AVGO

Broadcom

$295.33

-5.03 (-1.67%)

SYMC

Symbol changed to NLOK

$22.11

0.06 (0.27%)

  • 09

    Jul

AVGO Broadcom
$295.33

-5.03 (-1.67%)

06/14/19
CHLM
06/14/19
NO CHANGE
Target $315
CHLM
Buy
Broadcom price target lowered to $315 from $325 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Broadcom (AVGO) but lowered his price target to $315 after the company reported revenues below the Street and his estimate due to the impact of the Huawei ban as well as Apple (AAPL) weakness. Stoss tells investors in a research note that he still expects Broadcom to benefit from content growth at Apple this year due to the socket win back from Qorvo (QRVO) and new content associated with Wi-Fi 6 and says he continues to like Broadcom's position at Apple longer term and notes its recently signed two-year supply agreement positions the company well for 5G inclusion in iPhones likely coming next year.
06/14/19
RHCO
06/14/19
NO CHANGE
Target $307
RHCO
Buy
Broadcom price target lowered to $307 from $339 at SunTrust
SunTrust analyst William Stein lowered his price on Broadcom to $307 after its "mixed" Q1 results and reduced FY19 guidance "poured cold water" on the expected second-half of 2019 recovery in semiconductors. The analyst cites the management's acknowledgement that trade tensions and Huawei export ban make expectations of a second-half recovery unrealistic, but keeps his Buy rating on Broadcom and contends that the 8% sell-off in the stock price during the afterhours session was "at least partly overdone". Stein cuts his FY19 and FY20 EPS estimates by 33c and $2.68 to $22.24 and $24.98, but notes that Broadcom offers "good" margin stability, traction in CA Technologies performance, and dividend growth trajectory.
06/14/19
06/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Technologies (UTX) upgraded to Buy from Hold at Vertical Research. 2. Bluegreen Vacations (BXG) upgraded to Buy from Hold at Stifel with analyst Simon Yarmak saying that since BBX Capital (BBX) terminated its merger with Bluegreen on May 22, shares of the latter have traded off over 46%. 3. Broadcom (AVGO) upgraded to Buy from Hold at Summit Insights. 4. BJ's Restaurants (BJRI) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Bittner saying he sees an attractive entry point at current share levels. 5. Harmonic (HLIT) upgraded to Outperform from Market Perform at Raymond James with analyst Simon Leopold citing his belief that it benefits from the evolution of cable TV toward virtual Converged Cable Access Platforms and software. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/01/19
SBSH
07/01/19
NO CHANGE
SBSH
Citi sees semiconductor sector trading higher on lift of Huawei ban
Citi analyst Christopher Danely expects the semiconductor sector to trade higher after President Trump over the weekend lifted the ban on selling to Huawei and stated the U.S. would not go through with the additional $300B in tariffs. The analyst maintains his positive stance on the group and keeps a Buy ratings on Broadcom (AVGO), Microchip (MCHP), ON Semiconductor (ON) and Texas Instruments (TXN).
SYMC Symbol changed to NLOK
$22.11

0.06 (0.27%)

06/11/19
06/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities with analyst John Heagerty. 2. Symantec (SYMC) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Keith Weiss saying his recent survey of Chief Security Officers points to Symantec losing share in endpoint security and web security, which poses risk to its revenue growth guidance. 3. Shell Midstream (SHLX) downgraded to Underperform from Neutral at Credit Suisse with analyst Spiro Dounis noting that lower than anticipated re-contracted Zydeco pipeline rates result in a more challenged financial outlook that likely requires the Sponsor to remain accommodative. 4. Beyond Meat (BYND) downgraded to Neutral from Overweight at JPMorgan analyst Ken Goldman saying the stock at around $168 "requires assumptions we are not yet comfortable with." 5. Denny's (DENN) downgraded to Hold from Buy at Maxim with analyst Stephen Anderson saying that he remains "constructive" on the company's continued "brand rejuvenation" and refranchising program, modeling earning growth accelerating to 31% in 2020 from the projected 9% this year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
06/17/19
MZHO
06/17/19
UPGRADE
Target $23
MZHO
Buy
Symantec upgraded to Buy from Neutral at Mizuho
Mizuho analyst Gregg Moskowitz upgraded Symantec to Buy from Neutral and raised his price target for the shares to $23 from $22. While the company's execution has been weak and its competition "remains fierce," the stock's risk/reward has become "too attractive to ignore," Moskowitz tells investors in a research note. The analyst also believes Symantec's new management team will be much more focused on margin improvement, particularly within Enterprise Security. And while the company did announce an 8% headcount restructuring in August 2018, additional headcount cuts are likely going forward, adds Moskowitz. His sum-of-the-parts analysis suggests "healthy" share upside from here.
06/17/19
06/17/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Keurig Dr Pepper (KDP) upgraded to Outperform from Market Perform at BMO Capital with analyst Amit Sharma upgraded stating he company's "widening valuation discount" relative to non-alcoholic beverage peers has "become too large to ignore." 2. Symantec (SYMC) upgraded to Buy from Neutral at Mizuho with analyst Gregg Moskowitz saying while the company's execution has been weak and its competition "remains fierce," the stock's risk/reward has "too attractive to ignore." 3. Corteva (CTVA) upgraded to Buy from Hold at Deutsche Bank with analyst David Begleiter stating he believes a rally in corn prices bodes well for a stronger 2020. 4. ReWalk Robotics (RWLK) upgraded to Buy from Neutral at H.C. Wainwright with analyst Swayampakula Ramakanth saying ReWalk has delivered on several key milestones, including ReStore receiving both EU and U.S. regulatory approvals, progress regarding ReWalk reimbursement with U.S. private payers, and financial health improvements via additional funding. 5. Mosaic (MOS) upgraded to Buy from Neutral at BofA/Merrill with analyst Steve Byrne saying shares are down due to a combination of earnings risks, uncertainty associated with Brazilian tailings dams, and a weaker pricing outlook for phosphate and potash, but he feels that the longer-term potential upside outweighs near-term risks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/28/19
OTRG
06/28/19
NO CHANGE
OTRG
Crowdstrike 'stands out' in endpoint security market, says OTR Global
In a note to investors earlier, OTR Global said its checks with security distributors, resellers and system integrators showed that in a continued strong endpoint security market in Q2, CrowdStrike (CRWD) gained ground against incumbent vendors. The firm also noted that Carbon Black's (CBLK) Q2 endpoint sales met or exceeded plan for the majority of 11 partners the firm checked with and that only one of 14 sources said that Symantec's (SYMC) endpoint sales exceeded expectations in the quarter.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

09:33
11/13/19
11/13
09:33
11/13/19
09:33
General news
Powell says 'noteworthy risks' to baseline economic outlook remain »

Federal Reserve Chairman…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$308.96

0.57 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$89.00

6.3 (7.62%)

09:32
11/13/19
11/13
09:32
11/13/19
09:32
Recommendations
Tyson Foods analyst commentary  »

Tyson Foods price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPI

eXp World Holdings

$9.96

0.13 (1.32%)

09:32
11/13/19
11/13
09:32
11/13/19
09:32
Conference/Events
eXp World Holdings management to meet with DA Davidson »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

TRPX

Therapix Biosciences

$1.41

-0.16 (-10.19%)

09:32
11/13/19
11/13
09:32
11/13/19
09:32
Hot Stocks
Therapix Biosciences says Phase IIa study of THX-110 met primary endpoint »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLM

Martin Marietta

$255.29

-0.7 (-0.27%)

09:31
11/13/19
11/13
09:31
11/13/19
09:31
Conference/Events
House Science, Space & Technology Committee to hold a hearing »

The Subcommittee on Space…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EEFT

Euronet

$149.96

1.99 (1.34%)

09:30
11/13/19
11/13
09:30
11/13/19
09:30
Conference/Events
Euronet management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DG

Dollar General

09:30
11/13/19
11/13
09:30
11/13/19
09:30
Recommendations
Dollar General analyst commentary  »

Dollar General Q3 comp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

BGNE

BeiGene

$196.20

4.5 (2.35%)

09:30
11/13/19
11/13
09:30
11/13/19
09:30
Downgrade
BeiGene rating change  »

BeiGene downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 27

    Feb

DEO

Diageo

$157.94

-1.87 (-1.17%)

09:29
11/13/19
11/13
09:29
11/13/19
09:29
Conference/Events
Diageo management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DBD

Diebold

$8.10

0.025 (0.31%)

09:28
11/13/19
11/13
09:28
11/13/19
09:28
Conference/Events
Diebold management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CBPX

Continental Building

$35.76

3.73 (11.65%)

, GMS

GMS Inc.

$30.73

0.21 (0.69%)

09:27
11/13/19
11/13
09:27
11/13/19
09:27
Recommendations
Continental Building, GMS Inc., Foundation Building Materials analyst commentary  »

Continental Building…

CBPX

Continental Building

$35.76

3.73 (11.65%)

GMS

GMS Inc.

$30.73

0.21 (0.69%)

FBM

Foundation Building Materials

$21.20

0.2 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CRLBF

Cresco Labs

$0.00

(0.00%)

09:27
11/13/19
11/13
09:27
11/13/19
09:27
Conference/Events
Cresco Labs management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CNI

Canadian National

$93.08

-0.485 (-0.52%)

09:25
11/13/19
11/13
09:25
11/13/19
09:25
Conference/Events
Canadian National management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 21

    Nov

  • 22

    Nov

BRTX

BioRestorative Therapies

$0.00

(0.00%)

09:25
11/13/19
11/13
09:25
11/13/19
09:25
Conference/Events
BioRestorative Therapies to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

TLRY

Tilray

$21.57

-0.4 (-1.82%)

09:25
11/13/19
11/13
09:25
11/13/19
09:25
Recommendations
Tilray analyst commentary  »

Tilray price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
11/13/19
11/13
09:25
11/13/19
09:25
General news
Fed Chair Powell goes to Capitol Hill for his JEC testimony »

Fed Chair Powell goes to…

EL

Estee Lauder

$187.89

0.63 (0.34%)

09:24
11/13/19
11/13
09:24
11/13/19
09:24
Recommendations
Estee Lauder analyst commentary  »

Estee Lauder price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 06

    Feb

BWEN

Broadwind Energy

$1.53

(0.00%)

09:24
11/13/19
11/13
09:24
11/13/19
09:24
Conference/Events
Broadwind Energy management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BLDR

Builders FirstSource

$24.75

0.4 (1.64%)

09:22
11/13/19
11/13
09:22
11/13/19
09:22
Conference/Events
Builders FirstSource management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 05

    Dec

NVFY

Nova Lifestyle

$0.54

(0.00%)

09:21
11/13/19
11/13
09:21
11/13/19
09:21
Earnings
Nova Lifestyle reports Q3 revenue $9.3M vs. $16.7M last year »

Tawny Lam, Chairperson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMN

AMN Healthcare

$60.42

0.53 (0.88%)

09:20
11/13/19
11/13
09:20
11/13/19
09:20
Conference/Events
AMN Healthcare management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PHOT

GrowLife

$0.00

(0.00%)

09:20
11/13/19
11/13
09:20
11/13/19
09:20
Earnings
GrowLife reports Q3 revenue $2.3M vs. $1M last year »

GrowLife CEO Marco Hegyi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$28.32

-0.45 (-1.56%)

09:19
11/13/19
11/13
09:19
11/13/19
09:19
Conference/Events
Aimmune management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

NLTX

Neoleukin Therapeutics

$3.00

0.035 (1.18%)

09:19
11/13/19
11/13
09:19
11/13/19
09:19
Hot Stocks
Neoleukin Therapeutics expects cash to fund operations through 2021 »

Cash and cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLTX

Neoleukin Therapeutics

$3.00

0.035 (1.18%)

09:18
11/13/19
11/13
09:18
11/13/19
09:18
Earnings
Neoleukin Therapeutics reports Q3 EPS ($2.26), one est. (4c) »

"The past quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.